reference/10841175

Predicate	Object
contentType	Editorial\|Comment
endingPage	904
issn	0263-6352
issueIdentifier	5
pageRange	902-904
publicationName	Journal of Hypertension
startingPage	902
bibliographicCitation	Kjeldsen SE, Os I, Westheim A. Could adverse events offset the benefit of intensive blood pressure lowering treatment in the Systolic Blood Pressure Intervention Trial? J Hypertens. 2019 May;37(5):902–4. doi: 10.1097/hjh.0000000000002018. PMID: 30920495.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_10bf7577b87b6a09162935ddce3593ec http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_20ebb78cacdb67f1606514cb6bc0e7ac http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ebd70c1fefbaa45c67a2acd55ec2cd03
date	201905
identifier	https://pubmed.ncbi.nlm.nih.gov/30920495 https://doi.org/10.1097/hjh.0000000000002018
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4814 https://portal.issn.org/resource/ISSN/0263-6352
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Could adverse events offset the benefit of intensive blood pressure lowering treatment in the Systolic Blood Pressure Intervention Trial?
discusses	http://id.nlm.nih.gov/mesh/M0001456

Total number of triples: 21.